Ovid Therapeutics Drives Growth in Rare Neurological Disorder Biotech
Ovid Therapeutics targets rare neurological disorders, building a biotech pipeline to deliver unmet therapies. Learn how its research drives stock and value prospects.
2 minutes to read
